Moreover, we studied the expression of MIP-1α and MCP-1 by CD19/B-cells stimulated with both peptides, and found a significant increase in the expression of MIP-1α in ALS patients. This evidence concerns the gene CCL3 and amyotrophic lateral sclerosis.